PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7586124-2	1995	The genetic basis for butadiene carcinogenicity is likely mediated by its metabolite, 1,2:3,4-diepoxybutane (BDE).	1,3-butadiene	22-31	homeobox D13	Homo sapiens	109-112	
14594622-3	2003	PBDE commercial products are used as flame retardants in flexible polyurethane foam (penta-BDE), in acrylonitrile-butadiene-styrene resins (octa-BDE), and in high-impact polystyrene resins (deca-BDE).	1,3-butadiene	114-123	homeobox D13	Homo sapiens	1-4	
12482239-1	2002	Reactive metabolites of 1,3-butadiene, including 1,2-epoxy-3-butene (BDO), 1,2:3,4-diepoxybutane (BDO(2)), and 3,4-epoxy-1,2-butanediol (BDE), form both stable and unstable base adducts in DNA and have been implicated in producing genotoxic effects in rodents and human cells.	1,3-butadiene	24-37	homeobox D13	Homo sapiens	137-140	
8975787-1	1996	1,2:3,4-Diepoxybutane (BDE) is probably the ultimate genotoxic metabolite of the rodent carcinogen 1,3-butadiene (BD).	1,3-butadiene	99-112	homeobox D13	Homo sapiens	23-26	
7586124-3	1995	Oxidation of butadiene to 1,2-epoxy-3-butene (BMO) and further activation to BDE is catalysed by cytochrome P450 (CYP) isozymes.	1,3-butadiene	13-22	homeobox D13	Homo sapiens	77-80